Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ · Healthcare
Zentalis Pharmaceuticals, Inc. Net Income 2022–2025
Zentalis Pharmaceuticals, Inc. annual/quarterly net income history and growth rate from 2022 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Zentalis Pharmaceuticals, Inc. net income for the quarter ending September 30, 2025 was -26.7 M, a 33.54% decrease year-over-year.
- Zentalis Pharmaceuticals, Inc. net income for the twelve months ending September 30, 2025 was -142.0 M, a 42.34% decrease year-over-year.
- Zentalis Pharmaceuticals, Inc. annual net income for 2025 was -137.1 M, a 17.35% decrease from 2024.
- Zentalis Pharmaceuticals, Inc. annual net income for 2024 was -165.8 M, a 43.24% decrease from 2023.
- Zentalis Pharmaceuticals, Inc. annual net income for 2023 was -292.2 M, a 23.39% increase from 2022.
- Zentalis Pharmaceuticals, Inc. annual net income for 2022 was -236.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Zentalis Pharmaceuticals, Inc. Net Income — FAQ
Zentalis Pharmaceuticals, Inc. (ZNTL) net income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Zentalis Pharmaceuticals, Inc.'s net income?
Zentalis Pharmaceuticals, Inc. (ZNTL) reported net income of -$137M for fiscal 2025.
Where can I see ZNTL's net income history?
The chart and table above show Zentalis Pharmaceuticals, Inc.'s net income by year and by quarter, including the growth rate.